Injection of nanoparticle has proven effective in mouse models, researchers say
Researchers at Tel Aviv University have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer. Their innovative approach has so far proven effective in preventing the development of melanoma in mouse models and in treating primary tumors and metastases that result from melanoma.
The focus of the research is on a nanoparticle that serves as the basis for the new vaccine. The study was led by Prof. Ronit Satchi-Fainaro, chair of the Department of Physiology and Pharmacology and head of the Laboratory for Cancer Research and Nanomedicine at TAU’s Sackler Faculty of Medicine, and Prof. Helena Florindo of the University of Lisbon while on sabbatical at the Satchi-Fainaro lab at TAU; it was conducted by Dr. Anna Scomparin of Prof. Satchi-Fainaro’s TAU lab and postdoctoral fellow Dr. João Conniot. The results were published on August 5 in Nature Nanotechnology.
Melanoma develops in the skin cells that produce melanin or skin pigment. “The war against cancer in general, and melanoma in particular, has advanced over the years through a variety of treatment modalities, such as chemotherapy, radiation therapy and immunotherapy; but the vaccine approach, which has proven so effective against various viral diseases, has not materialized yet against cancer,” says Prof. Satchi-Fainaro. “In our study, we have shown for the first time that it is possible to produce an effective nano-vaccine against melanoma and to sensitize the immune system to immunotherapies.”
The researchers harnessed tiny particles, about 170 nanometers in size, made of a biodegradable polymer. Within each particle, they “packed” two peptides — short chains of amino acids, which are expressed in melanoma cells. They then injected the nanoparticles (or “nano-vaccines”) into a mouse model bearing melanoma.
“The nanoparticles acted just like known vaccines for viral-borne diseases,” Prof. Satchi-Fainaro explains. “They stimulated the immune system of the mice, and the immune cells learned to identify and attack cells containing the two peptides — that is, the melanoma cells. This meant that, from now on, the immune system of the immunized mice will attack melanoma cells if and when they appear in the body.”
The researchers then examined the effectiveness of the vaccine under three different conditions.
First, the vaccine proved to have prophylactic effects. The vaccine was injected into healthy mice, and an injection of melanoma cells followed. “The result was that the mice did not get sick, meaning that the vaccine prevented the disease,” says Prof. Satchi-Fainaro.
Second, the nanoparticle was used to treat a primary tumor: A combination of the innovative vaccine and immunotherapy treatments was tested on melanoma model mice. The synergistic treatment significantly delayed the progression of the disease and greatly extended the lives of all treated mice.
Finally, the researchers validated their approach on tissues taken from patients with melanoma brain metastases. This suggested that the nano-vaccine can be used to treat brain metastases as well. Mouse models with late-stage melanoma brain metastases had already been established following excision of the primary melanoma lesion, mimicking the clinical setting. Research on image-guided surgery of primary melanoma using smart probes was published last year by Prof. Satchi-Fainaro’s lab.
“Our research opens the door to a completely new approach — the vaccine approach — for effective treatment of melanoma, even in the most advanced stages of the disease,” concludes Prof. Satchi-Fainaro. “We believe that our platform may also be suitable for other types of cancer and that our work is a solid foundation for the development of other cancer nano-vaccines.”
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- What are the Statistics of Melanoma?on August 4, 2022 at 7:03 am
Yolanda graduated with a Bachelor of Pharmacy at the University of South Australia and has experience working in both Australia and Italy. She is passionate about how medicine, diet and lifestyle ...
- Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Updateon August 4, 2022 at 5:02 am
First 75 patients enrolled in the IGNYTE clinical trial cohort of RP1 combined with Opdivo®(nivolumab) in anti-PD1 failed melanoma; data snapshot from these patients with six-month follow-up expected ...
- Sunbed use before the age of 35 increases risk of melanoma by 75pcon August 4, 2022 at 3:27 am
People who have used a sunbed before the age of 35 increase their risk of developing melanoma by 75pc, according to research.
- Mobile Applications for Melanoma Detection Market 2022 Outlook By Industry Size, Share, Revenue, Regions, and Forecast to 2030on August 3, 2022 at 9:12 pm
The mobile applications for melanoma detection market in Europe and Israel is projected to grow at a CAGR of more than ...
- Ocular Melanomaon August 3, 2022 at 12:24 pm
Ocular melanoma is a form of cancer that begins, most commonly, in the uveal layer of the eye that forms the capsule of the eye just below the sclera, or white portion. The choroid is the largest ...
- Sentinel Lymph Node Biopsy Can Be Therapeutic in Melanoma Patientson August 3, 2022 at 9:03 am
Sentinel lymph node (SLN) biopsy without completion lymph node dissection (CLND) led to regional nodal disease control in melanoma patients, even those with risk factors for in-basin recurrence, ...
- 'RNA fishing' reveals new driver of melanoma malignancy and metastasison August 3, 2022 at 7:41 am
Researchers at the Center for Genomic Regulation (CRG) have identified several proteins involved in the progression of melanoma, the deadliest form of skin cancer. One of the proteins—PDIA6—was found ...
- It’s a myth that sunscreen prevents melanoma in people of coloron July 27, 2022 at 2:30 pm
Melanoma is a potentially deadly form of skin cancer that effects people of every racial and ethnic group. The risk factor most closely linked to developing melanoma is exposure to ultraviolet, or UV, ...
- AI and Dermatologists Similarly Judge Melanoma Thicknesson July 27, 2022 at 8:18 am
Both readers and artificial intelligence predict melanoma thickness with fair to moderate accuracy using dermoscopy images, according to a study published online July 16 in the Journal of the European ...
- Dr Vernon Sondak on BRAF Mutations in Metastatic Melanomaon July 22, 2022 at 11:15 am
In this interview, Vernon Sondak, MD, the chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Florida, explains the latest approach to treating ...
via Bing News